Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.
Investment adviser Innovatus Capital Partners has agreed to provide up to $42m in funding for Personal Genome Diagnostics (PGDx), a US-based oncology diagnostics developer spun out of Johns Hopkins University.
PGDx is developing in vitro genomic liquid and tissue-based biopsy products that will be able to help physicians fine tune treatments for cancer patients based on the precise characteristics of their disease.
The technology is based on research conducted by co-founders Luis Diaz Jr, an associate professor of…
